|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/28 | |
| A61K 31/4402 | |||
| A61K 31/4415 | |||
| A61K 9/32 | |||
| A61K 9/42 | |||
| A61P 1/08 |
| (11) | Number of the document | 3185856 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14900963.1 |
| Date of filing the European patent application | 2014-08-29 | |
| (97) | Date of publication of the European application | 2017-07-05 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2014/050828 |
| Date | 2014-08-29 |
| (87) | Number | WO 2016/029290 |
| Date | 2016-03-03 |
| (72) |
VRANDERICK, Manon, CA
ST-ONGE, Jean-Luc, CA
GALLO, Michele, CA
GERVAIS, Éric, CA
|
| (73) |
Duchesnay Inc.,
950 Boul. Michele-Bohec, Blainville, Québec J7C 5E2,
CA
|
| (54) | PLURIMODAL RELEASE FORMULATION OF DOXYLAMINE AND PYRIDOXINE AND/OR METABOLITES OR SALTS THEREOF |
| PLURIMODAL RELEASE FORMULATION OF DOXYLAMINE AND PYRIDOXINE AND/OR METABOLITES OR SALTS THEREOF |